The American Brain Foundation's Next Generation Research Grants (NGRGs) support early career investigators conducting high-quality research aimed at better understanding, treating, and curing brain diseases. These grants are funded in collaboration with disease-focused partner organizations and are administered directly by the American Brain Foundation. These grants seek to advance research in specific topics while also reflecting ABF’s Cure One, Cure Many research philosophy: the belief that breakthroughs in one area of research accelerate progress across many others.
Each grant in the NGRG program has its own focus area, funding level, and eligibility requirements. Applicants should review the grant-specific RFP for each award they wish to apply for. Eligibility and requirements vary by grant; reading each RFP carefully before applying is strongly encouraged.
Next Generation Research Grant
$150,000
October 8, 2026
Other Funding Supplementation of an NGRG award with other grants is permitted. However, to be eligible to apply, any other grant source(s) cannot exceed the ABF award amount annually. This policy is intended to help ensure that ABF funding reaches as many researchers as possible. If you have questions about whether your current funding affects your eligibility, please contact us before applying.
Evaluation and Selection
Applications are reviewed by a selection committee of scientific experts convened by the American Brain Foundation and its funding partners. Proposals are evaluated according to the criteria listed in the individual grant RFP. All grants share the following core review criteria:
• Scientific rationale, innovation, and methodological rigor, including a well-developed and testable hypothesis
• Potential clinical impact and translational value
• Alignment with the research priorities of the grant
• Investigator expertise and potential for an independent research career
• Feasibility of proposed aims, including identification of potential pitfalls and alternative approaches
• Quality and nature of mentorship, including demonstrated commitment to the applicant's training and career development
This is the most important fit factor.
ABF explicitly funds research across the broad spectrum of brain and nervous-system diseases rather than concentrating exclusively on one condition. Its funded research has included ALS, multiple sclerosis, Parkinson's disease, epilepsy, dementia, stroke, peripheral neuropathy, neuromuscular disease and neurodevelopmental disorders.
High-fit areas include:
A competitive proposal should address a substantial unanswered problem.
Strong questions may concern:
The application should clearly establish:
Major neurological problem → critical knowledge gap → proposed research → potential solution.
This is central to ABF's mission. ABF describes its research objective as improving prevention, diagnosis and treatment, while pursuing treatments and cures across brain diseases.
Particularly compelling outcomes include:
ABF strongly values innovative research. Its Next Generation program specifically supports innovative investigations, while Cure One, Cure Many targets highly innovative, cross-cutting approaches to diagnosis, treatment and cures.
Potentially strong approaches include:
The proposal should make the scientific logic easy to follow:
What is known?
↓
What is unknown?
↓
Why does it matter?
↓
What is your hypothesis?
↓
How will you test it?
↓
What will change if you are correct?
ABF's recent awards demonstrate a mixture of mechanistic, biomarker, clinical and translational projects.
Strong applications should demonstrate:
For clinical studies, recruitment and follow-up must be realistic.
For laboratory research, appropriate models and controls are essential.
The strongest projects can show a pathway from discovery toward patient benefit.
Example:
Disease mechanism → biomarker → clinical validation → earlier diagnosis
or
Disease mechanism → therapeutic target → preclinical validation → clinical treatment
ABF's Cure One, Cure Many philosophy particularly favors discoveries that may have relevance across multiple brain diseases. Its 2026 awards, for example, included work on Lewy body dementia biomarkers and neuroinflammation across brain diseases.
This is particularly important for the Next Generation Research Grant, which is designed to support innovative work by early-career investigators and help establish long-term research careers.
A strong early-career applicant should demonstrate:
ABF reports that 98% of its researchers have subsequently obtained funding from NIH or other major national funders, demonstrating the Foundation's strong emphasis on developing research careers.
The proposal should demonstrate access to:
The project should be ambitious enough to be meaningful but realistic enough to complete.
This factor becomes especially important for Cure One, Cure Many proposals.
ABF's philosophy is that discoveries in one brain disease can lead to advances in other related neurological conditions.
All NGRG grants share the following eligibility requirements. Individual grants may have additional requirements — see each grant's RFP for details.
• Applicants must hold an MD, PhD, or equivalent terminal-level clinical or research degree.
• The research proposed must be relevant to the disease focus of the grant to which the applicant is applying.
• Applicants may apply for more than one NGRG grant in a single cycle. A separate, complete application must be submitted for each grant.
• Applicants who are not selected for funding are encouraged to reapply in future cycles.
The American Brain Foundation is committed to supporting research that incorporates a broad range of perspectives and reflects the full spectrum of individuals affected by brain disease. The ABF provides equal opportunities to all applicants without regard to race, religion, color, age, sex, pregnancy, national origin, sexual orientation, gender identity, genetic disposition, neurodiversity, disability, veteran status, or any other protected category under applicable law.
Sponsor Institute/Organizations: American Brain Foundation
Sponsor Type: Corporate/Non-Profit
Address: PO Box 176 Wheaton, IL 60187
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Oct 08, 2026
Oct 08, 2026
$150,000
Affiliation: American Brain Foundation
Address: PO Box 176 Wheaton, IL 60187
Website URL: https://www.americanbrainfoundation.org/wp-content/uploads/2026/08/ABF-Next-Gen-RFP-Overview-2027.pdf
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.